Adipokines: a Link Between Obesity and Dementia?

Overview

Journal Lancet Neurol

Specialty Neurology

Date 2014 Aug 22

PMID 25142458

Citations 133

Authors

Amanda J Kiliaan

Ilse A C Arnoldussen

Deborah R Gustafson

Affiliations

Soon will be listed here.

Abstract

Being overweight or obese, as measured with body-mass index or central adiposity (waist circumference), and the trajectory of body-mass index over the life course have been associated with brain atrophy, white matter changes, disturbances of blood-brain barrier integrity, and risk of all-cause late-onset dementia and Alzheimer's disease. This observation leads us to question what it is about body-mass index that is associated with health of the brain and dementia risk. If high body-mass index and central adiposity represent an increase in adipose tissue, then the endocrine function of adipose tissue, mediated by adipose tissue hormones and adipokines, could be a clue to mechanisms that underlie the association with dementia and Alzheimer's disease. Hundreds of adipokines have been identified, creating a complexity that is a challenge to simplify. Nonetheless, adipokines are being investigated in association with clinical dementia outcomes, and with imaging-based measures of brain volume, structure, and function in human beings and in preclinical models of clinical dementia.

Citing Articles

Trajectories of general and central obesity beyond middle age in relation to late-life cognitive decline and dementia.

Liang Z, Qin H, Su B, Bao Y, Vitiello M, Hu G Obesity (Silver Spring). 2025; 33(2):405-415.

PMID: 39873393 PMC: 11774005. DOI: 10.1002/oby.24208.

Oral administration of to mice with diet-induced obesity impairs cognitive function associated with microglial activation in the brain.

Oue K, Yamawaki Y, Ouhara K, Imado E, Tamura T, Doi M J Oral Microbiol. 2024; 16(1):2419155.

PMID: 39553478 PMC: 11565673. DOI: 10.1080/20002297.2024.2419155.

Associations of metabolic heterogeneity of obesity with the risk of dementia in middle-aged adults: three prospective studies.

Ding Y, Ge T, Shen J, Duan M, Yuan C, Zhu Y Alzheimers Res Ther. 2024; 16(1):220.

PMID: 39394616 PMC: 11468300. DOI: 10.1186/s13195-024-01581-x.

Association between Visceral Adipose Tissue Metabolism and Cerebral Glucose Metabolism in Patients with Cognitive Impairment.

Yu M, Lim J, Yi H, Won K, Kim H Int J Mol Sci. 2024; 25(13).

PMID: 39000586 PMC: 11242271. DOI: 10.3390/ijms25137479.

Impaired Remodeling of White Adipose Tissue in Obesity and Aging: From Defective Adipogenesis to Adipose Organ Dysfunction.

Iacobini C, Vitale M, Haxhi J, Menini S, Pugliese G Cells. 2024; 13(9.

PMID: 38727299 PMC: 11083890. DOI: 10.3390/cells13090763.

References

Wenk G . Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry. 2003; 64 Suppl 9:7-10. View

Gustafson D . Adiposity and cognitive decline: underlying mechanisms. J Alzheimers Dis. 2012; 30 Suppl 2:S97-112. DOI: 10.3233/JAD-2012-120487. View

Giordano P, Del Vecchio G, Cecinati V, Delvecchio M, Altomare M, De Palma F . Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents. Eur J Pediatr. 2011; 170(7):845-50. DOI: 10.1007/s00431-010-1356-7. View

Das U . Is obesity an inflammatory condition?. Nutrition. 2001; 17(11-12):953-66. DOI: 10.1016/s0899-9007(01)00672-4. View

Blasko I, Lederer W, Oberbauer H, Walch T, Kemmler G, Hinterhuber H . Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias. Dement Geriatr Cogn Disord. 2005; 21(1):9-15. DOI: 10.1159/000089137. View

Chandran M, Phillips S, Ciaraldi T, Henry R . Adiponectin: more than just another fat cell hormone?. Diabetes Care. 2003; 26(8):2442-50. DOI: 10.2337/diacare.26.8.2442. View

Banks W . Is obesity a disease of the blood-brain barrier? Physiological, pathological, and evolutionary considerations. Curr Pharm Des. 2003; 9(10):801-9. DOI: 10.2174/1381612033455350. View

Bluher M . Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes. 2009; 117(6):241-50. DOI: 10.1055/s-0029-1192044. View

Harvey J, Shanley L, OMalley D, Irving A . Leptin: a potential cognitive enhancer?. Biochem Soc Trans. 2005; 33(Pt 5):1029-32. DOI: 10.1042/BST20051029. View

10.

Seidell J, Oosterlee A, Deurenberg P, Hautvast J, Ruijs J . Abdominal fat depots measured with computed tomography: effects of degree of obesity, sex, and age. Eur J Clin Nutr. 1988; 42(9):805-15. View

11.

Lieb W, Beiser A, Vasan R, Tan Z, Au R, Harris T . Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA. 2009; 302(23):2565-72. PMC: 2838501. DOI: 10.1001/jama.2009.1836. View

12.

Searfoss G, Jordan W, Calligaro D, Galbreath E, Schirtzinger L, Berridge B . Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor. J Biol Chem. 2003; 278(46):46107-16. DOI: 10.1074/jbc.M307757200. View

13.

Stevens J, Cai J, Pamuk E, Williamson D, Thun M, Wood J . The effect of age on the association between body-mass index and mortality. N Engl J Med. 1998; 338(1):1-7. DOI: 10.1056/NEJM199801013380101. View

14.

Jung C, Fritzenwanger M, Fischer N, Figulla H . Hepatocyte growth factor is elevated in obese adolescents. J Pediatr Endocrinol Metab. 2009; 22(7):645-51. DOI: 10.1515/jpem.2009.22.7.645. View

15.

Kos K, Harte A, da Silva N, Tonchev A, Chaldakov G, James S . Adiponectin and resistin in human cerebrospinal fluid and expression of adiponectin receptors in the human hypothalamus. J Clin Endocrinol Metab. 2007; 92(3):1129-36. DOI: 10.1210/jc.2006-1841. View

16.

Khan U, Wang D, Sowers M, Mancuso P, Everson-Rose S, Scherer P . Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN). Metabolism. 2012; 61(9):1261-9. PMC: 3404256. DOI: 10.1016/j.metabol.2012.02.005. View

17.

Ropelle E, Flores M, Cintra D, Rocha G, Pauli J, Morari J . IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition. PLoS Biol. 2010; 8(8). PMC: 2927536. DOI: 10.1371/journal.pbio.1000465. View

18.

Morash B, Li A, Murphy P, WILKINSON M, Ur E . Leptin gene expression in the brain and pituitary gland. Endocrinology. 1999; 140(12):5995-8. DOI: 10.1210/endo.140.12.7288. View

19.

Qiu G, Wan R, Hu J, Mattson M, Spangler E, Liu S . Adiponectin protects rat hippocampal neurons against excitotoxicity. Age (Dordr). 2010; 33(2):155-65. PMC: 3127462. DOI: 10.1007/s11357-010-9173-5. View

20.

Duvnjak L, Duvnjak M . The metabolic syndrome - an ongoing story. J Physiol Pharmacol. 2010; 60 Suppl 7:19-24. View